受强制性开放获取政策约束的文章 - Michael Cloesmeijer了解详情
可在其他位置公开访问的文章：15 篇
Application of SHAP values for inferring the optimal functional form of covariates in pharmacokinetic modeling
A Janssen, M Hoogendoorn, MH Cnossen, RAA Mathôt, ...
CPT: Pharmacometrics & Systems Pharmacology 11 (8), 1100-1110, 2022
强制性开放获取政策： Canadian Institutes of Health Research, Netherlands Organisation for …
Deep compartment models: a deep learning approach for the reliable prediction of time‐series data in pharmacokinetic modeling
A Janssen, FWG Leebeek, MH Cnossen, RAA Mathôt, ...
CPT: Pharmacometrics & Systems Pharmacology 11 (7), 934-945, 2022
强制性开放获取政策： Canadian Institutes of Health Research, Netherlands Organisation for …
ChatGPT in pharmacometrics? Potential opportunities and limitations
ME Cloesmeijer, A Janssen, SF Koopman, MH Cnossen, RAA Mathôt, ...
British journal of clinical pharmacology 90 (1), 360-365, 2024
强制性开放获取政策： Netherlands Organisation for Scientific Research, Netherlands Organisation …
SYMPHONY consortium: Orchestrating personalized treatment for patients with bleeding disorders
MH Cnossen, I van Moort, SH Reitsma, MPM de Maat, REG Schutgens, ...
Journal of Thrombosis and Haemostasis 20 (9), 2001-2011, 2022
强制性开放获取政策： Netherlands Organisation for Scientific Research
Perioperative pharmacokinetic-guided factor VIII concentrate dosing in haemophilia (OPTI-CLOT trial): an open-label, multicentre, randomised, controlled trial
I van Moort, T Preijers, LH Bukkems, HCAM Hazendonk, JG van der Bom, ...
The Lancet Haematology 8 (7), e492-e502, 2021
强制性开放获取政策： Netherlands Organisation for Scientific Research, Netherlands Organisation …
A Generative and Causal Pharmacokinetic Model for Factor VIII in Hemophilia A: A Machine Learning Framework for Continuous Model Refinement
A Janssen, L Smalbil, FC Bennis, MH Cnossen, RAA Mathôt, ...
Clinical Pharmacology & Therapeutics 115 (4), 881-889, 2024
强制性开放获取政策： Netherlands Organisation for Scientific Research, Netherlands Organisation …
Transcriptional and functional profiling identifies inflammation and endothelial-to-mesenchymal transition as potential drivers for phenotypic heterogeneity within a cohort of …
SNJ Laan, S de Boer, RJ Dirven, I van Moort, TB Kuipers, H Mei, ...
Journal of Thrombosis and Haemostasis, 2024
强制性开放获取政策： Netherlands Organisation for Scientific Research
Quantification of the relationship between desmopressin concentration and Von Willebrand factor in Von Willebrand disease type 1: A pharmacodynamic study
JM Heijdra, ME Cloesmeijer, NCB de Jager, FWG Leebeek, MHJA Kruip, ...
Haemophilia 28 (5), 814-821, 2022
强制性开放获取政策： Netherlands Organisation for Scientific Research, Netherlands Organisation …
Desmopressin testing in von Willebrand disease: Lowering the burden
JM Heijdra, F Atiq, W Al Arashi, Q Kieboom, E Wuijster, K Meijer, ...
Research and practice in thrombosis and haemostasis 6 (6), e12784, 2022
强制性开放获取政策： Netherlands Organisation for Scientific Research, Netherlands Organisation …
Is pharmacokinetic-guided dosing of desmopressin and von Willebrand factor-containing concentrates in individuals with von Willebrand disease or low von Willebrand factor …
JM Heijdra, W Al Arashi, NCB De Jager, ME Cloesmeijer, LH Bukkems, ...
BMJ open 12 (2), e049493, 2022
强制性开放获取政策： Netherlands Organisation for Scientific Research, Netherlands Organisation …
Replacement therapy in pregnant women with von Willebrand disease during delivery: Factor levels and pharmacokinetics
W Al Arashi, ME Cloesmeijer, FWG Leebeek, JJ Duvekot, MJHA Kruip, ...
HemaSphere 9 (1), e70061, 2025
强制性开放获取政策： Netherlands Organisation for Scientific Research, Netherlands Organisation …
Functional characterization of a nanobody-based glycoprotein VI-specific platelet agonist
M Zivkovic, E Pols-van Veen, V van der Vegte, SAE Sebastian, ...
Research and Practice in Thrombosis and Haemostasis 8 (7), 102582, 2024
强制性开放获取政策： Netherlands Organisation for Scientific Research
PBPK modeling of recombinant factor IX Fc fusion protein (rFIXFc) and rFIX to characterize the binding to type 4 collagen in the extravascular space
ME Cloesmeijer, E Sjögren, SF Koopman, PJ Lenting, MH Cnossen, ...
CPT: Pharmacometrics & Systems Pharmacology 13 (10), 1630-1640, 2024
强制性开放获取政策： Netherlands Organisation for Scientific Research
Pharmacokinetic–Pharmacodynamic Modelling in Hemophilia A: Relating Thrombin and Plasmin Generation to Factor VIII Activity After Administration of a VWF/FVIII Concentrate
LLFG Valke, ME Cloesmeijer, H Mansouritorghabeh, W Barteling, ...
European Journal of Drug Metabolism and Pharmacokinetics 49 (2), 191-205, 2024
强制性开放获取政策： Netherlands Organisation for Scientific Research, Netherlands Organisation …
Protocol: Is pharmacokinetic-guided dosing of desmopressin and von Willebrand factor-containing concentrates in individuals with von Willebrand disease or low von Willebrand …
JM Heijdra, W Al Arashi, NCB de Jager, ME Cloesmeijer, LH Bukkems, ...
BMJ Open 12 (2), 2022
强制性开放获取政策： Netherlands Organisation for Scientific Research, Netherlands Organisation …
出版信息和资助信息由计算机程序自动确定